[1]
Laganà, A. et al. 2024. Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis . Mediterranean Journal of Hematology and Infectious Diseases. 16, 1 (Apr. 2024), e2024047. DOI:https://doi.org/10.4084/MJHID.2024.047.